About AVATROMBOPAG
            
            Class: | Thrombopoietin receptor agonist  
Use: | Treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a procedure  
Adult dose: | 20 mg orally once daily, starting 10 to 13 days prior to the procedure  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Headache, fatigue, nausea, diarrhea, abdominal pain, and increased liver enzymes  
Contraindications: | Hypersensitivity to avatrombopag or any component of th
         
        
            
                
                
                    
                        Drug Class
                    
                    Thrombopoietin receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a procedure
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Swedish Orphan Biovitrum AB, SWEDEN
                    
                    
                    Package Size
                    15's Blister
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4609.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        20 mg orally once daily, starting 10 to 13 days prior to the procedure
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, fatigue, nausea, diarrhea, abdominal pain, and increased liver enzymes
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to avatrombopag or any component of the formulation; active or uncontrolled thromboembolic disease
         
        
        
            
                Important Warnings
            
            Risk of thromboembolic events; monitor platelet counts; not for use in patients with a history of thromboembolic events or those with active liver disease requiring urgent intervention
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.